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Ventral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the
expression of heroin-conditioned immunomodulation
Abstract

The present investigations sought to determine whether the ventral tegmental area (VTA),
basolateral amygdala (BLA), and nucleus accumbens shell (NAC) comprise a circuitry that
mediates heroin-induced conditioned immunomodulation. Rats were given conditioning trials in
which they received an injection of heroin upon placement into a distinctive environment. Prior
to testing, rats received unilateral intra-BLA microinfusion of a D1 antagonist concomitantly
with unilateral intra-NAC shell microinfusion of an NMDA antagonist. Disconnection of the
VTA–BLA–NAC circuit impaired the ability of the heroin-paired environment to suppress
lipopolysaccharide-induced immune responses, defining for the first time a specific neural circuit
involved in conditioned neural-immune interactions.
1. Introduction

Opioid treatment in rats suppresses a number of in vivo immune responses, including the
production of nitric oxide, a key component of host defense against bacterial infection (e.g.,
Lysle et al., 1993, Fecho et al., 1996a, Fecho et al., 1996b, Lysle and How, 2000, Nelson et al.,
2000). In addition, opioid drugs also suppress in vivo expression of proinflammatory cytokines
(Chao et al., 1993, Benscsics et al., 1997, Pacifici et al., 2000, Clark et al., 2007).
Proinflammatory cytokines, such as IL-6 and TNF-α, play critical roles in the body's defense
against infectious challenge, while also serving to regulate the immune response to these
challenges. There is now substantial evidence that these effects of opioid drugs on the immune

system are generated via actions within the CNS. For example, intraventricularly administered
N-methylnaltrexone (an opioid antagonist that does not readily cross the blood–brain barrier)
dose-dependently antagonizes the immunomodulatory effects of systemic morphine
administration, whereas peripheral administration of N-methylnaltrexone is ineffective in
blocking morphine's effects (Fecho et al., 1996a, Lysle et al., 1996). Furthermore, microinjection
of morphine into the periacqueductal gray results in suppression of NK cell cytotoxicity which
can be blocked by peripheral administration of naltrexone, an opioid antagonist (Weber and Pert,
1989). Remarkably, the suppressive effects of opioids on the immune system can be conditioned
to environmental stimuli paired with drug administration (Lysle and Ijames, 2002) such that the
previously heroin-paired environment alone elicits heroin-like changes in immune functioning.
Conditioned immune alterations brought about by exposure to drug cues may manifest as an
increased susceptibility to opportunistic infections and a decreased ability to combat infectious
diseases in recovering drug users. A clear understanding of the neurotransmitters and neural
circuitry involved in heroin-conditioned immunomodulation is necessary for the development of
pharmacotherapeutic interventions that might be employed in susceptible populations before
infections lead to irreversible organ damage and other detrimental health consequences.

Recent studies in our laboratory and others have identified key brain structures involved in the
mediation of conditioned immunomodulation. For example, several brain structures are critically
involved in the expression and acquisition of immune alterations in a conditioned taste aversion
model. These include the insular cortex, amygdala and the ventromedial nucleus of the
hypothalamus (Ramirez-Amaya et al., 1996, Ramirez-Amaya et al., 1998, Ramirez-Amaya and
Bermudez-Rattoni, 1999, Chen et al., 2004, Pacheco-Lopez et al., 2005). Our own laboratory

recently demonstrated that dopamine neurotransmission in the basolateral amygdala (BLA) and
nucleus accumbens shell (NAC) is necessary for heroin-conditioned and morphine-conditioned
immunomodulation, respectively (Szczytkowski and Lysle, 2008, Saurer et al., 2009).
Specifically, D1 dopaminergic receptor antagonism in these structures inhibits conditioned
decreases in the production of proinflammatory mediators in peripheral immune tissues
(Szczytkowski and Lysle, 2010). This implies that the ventral tegmental area (VTA), the primary
source of dopamine to the BLA in the rat (Ford et al., 2006), is an element of the neural circuitry
mediating heroin-conditioned immune regulation. In addition to dopamine, glutamate input to
the NAC is important for conditioned behaviors. For instance, AMPA or NMDA receptor
antagonism in the NAC disrupts 7-OH-DPAT conditioned place preference (Biondo et al., 2005)
and AMPA antagonism in the NAC inhibits cocaine context-induced drug seeking behavior (Xie
et al., in press). Despite these significant findings regarding the contributions of individual brain
regions, no attempt has been made to identify functionally significant connections between these
brain regions thus to map the neural circuitry responsible for heroin-induced conditioned
immunomodulation, specifically, or for conditioned immune alterations, in general. Given the
critical role of dopamine in the BLA in conditioned immunomodulation and the existence of
glutamatergic BLA afferents to the NAC (Kelley et al., 1982, McDonald, 1991, Wright et al.,
1996), we hypothesized that the VTA–BLA–NAC circuitry may control the conditioned effects
of heroin on immune measures.

To begin testing this hypothesis, we first evaluated whether ionotropic glutamate receptor
antagonism in the NAC shell would block heroin-conditioned suppression of nitric oxide and the
proinflammatory cytokines, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), in

response to a lipopolysaccharide (LPS) immune challenge. Research has shown a role for both
NMDA and AMPA/kainate receptors in various drug-conditioned responses (Hotsenpiller et al.,
2001, Rodriguez-Borrero et al., 2006, Backstrom and Hyytia, 2007). Therefore, we investigated
whether either of these receptors in the NAC shell contributes to conditioned
immunomodulation.

The results of experiment 1 supported the hypothesis that glutamatergic input in the NAC shell
regulates conditioned immunomodulation and set the stage for experiment 2 in which we tested
the hypothesis that communication within the VTA–BLA–NAC circuitry, via the stimulation of
D1 dopamine receptors in the BLA and NMDA receptors in the NAC, is necessary for the
expression of conditioned immunomodulation. This experiment took advantage of the functional
disconnection procedure which has been utilized previously to demonstrate the serial
connectivity between brain regions necessary for the expression of motivated behavior in animal
models of addiction (Di Ciano and Everitt, 2004, Fuchs et al., 2007, Belin and Everitt, 2008,
Lasseter et al., 2011). The premise of the functional disconnection procedure is that unilateral
antagonism of one brain region combined with contralateral antagonism of another brain region
produces greater functional impairment than ipsilateral antagonism of these brain regions if, in
fact, intrahemispheric interactions between these brain structures are functionally necessary
(Parkinson et al., 2000). This research endeavor was undertaken to explore, for the first time, the
involvement of a multi-synaptic neural circuit in the control of neural-immune interactions and,
specifically, in the expression of heroin-induced conditioned immune alterations.
2. Materials and methods
2.1. Animals

Male Lewis rats, weighing 225–250 g, were purchased from Charles River Laboratories
(Raleigh, N.C., USA). Animals were housed individually in plastic cages in a colony room with
a reversed light–dark (12 h) cycle maintained through artificial illumination. Access to food and
water was given ad libitum throughout the experiment except for the time spent in the
conditioning chambers when food and water were not available. Animals were given a 2-week
habituation period before the start of experimental manipulations and were handled regularly
during this time. All procedures were approved by the IACUC of the University of North
Carolina at Chapel Hill and conformed to National Institutes of Health (NIH) Guidelines on the
Care and Use of Laboratory Animals.
2.2. Surgical procedure

Animals were anesthetized with 0.35 ml intramuscular injections of 9:1 (vol/vol) ketamine
hydrochloride (100 mg/ml) mixed with xylazine (100 mg/ml) and placed into the stereotaxic
apparatus. Animals were implanted with 26-gauge bilateral guide cannula (Plastics One,
Roanoke, VA) directed unilaterally toward the BLA (AP − 2.5, ML ± 5.0, DV − 6.6) and/or
bilaterally towards the NAC shell (AP + 1.7, ML ± 0.8, DV − 5.4). Coordinates are expressed as
millimeters from bregma (Paxinos and Watson, 1997). Animals were given two weeks to recover
from surgery before the start of conditioning trials.
2.3. Classical conditioning procedure

To condition heroin's immunomodulatory effects, all animals received five 60-min training
sessions in which they received a subcutaneous injection of heroin (diacethylmorphine, 1 mg/kg,

sc; NIDA Drug Supply System, Bethesda, MD), dissolved in 0.9% sterile saline, immediately
prior to placement into a standard conditioning chamber. This heroin dose was selected based on
prior experiments in our laboratory showing that it induces conditioned alterations in LPSinduced iNOS and TNF-α mRNA expression in spleen tissue (Lysle and Ijames, 2002,
Szczytkowski and Lysle, 2007). Training sessions were separated by 48 h.

The conditioning chambers (BRS/LVE, Laurel, MD, USA) were located in a room separate from
the animal colony and contained a metal grid floor and cedar bedding to create an environment
distinct from the home cage. All conditioning took place during the dark phase of the light cycle
and the conditioning chambers were kept dark. Previous studies have shown that animals that
undergo this procedure and are later exposed to the previously heroin-paired environment
demonstrate robust suppression of immunological parameters, including reduced nitric oxide
production and proinflammatory cytokine expression (Lysle and Ijames, 2002, Szczytkowski and
Lysle, 2008, Szczytkowski and Lysle, 2010).
2.4. Behavioral testing

Six days following the final conditioning session, animals were re-exposed to the conditioned
stimulus (i.e., the conditioning chambers) without further drug administration to determine
whether the conditioned stimulus alone would induce alterations in proinflammatory mediators.
Thirty minutes prior to the test session, animals received bilateral intra-NAC microinfusions of
an ionotropic glutamate antagonist (AMPA/kainate receptor antagonist: CNQX, 2.5 μg/0.5
μl/hemisphere; or NMDA receptor antagonist: AP-5, 1.0 μg/0.5 μl/hemisphere; Experiment 1) or
a unilateral microinfusion of the D1 antagonist, SCH23390 (2 μg/0.5 μl/hemisphere), into the

BLA concomitant with either an ipsilateral or contralateral microinfusion of the NMDA receptor
antagonist, AP-5 (1.0 μg/0.5 μl/hemisphere) into the NAC shell (Experiment 2). Control animals
received microinfusions of saline vehicle (0.5 μl/hemisphere infused). The antagonist doses and
volumes were chosen based upon previous behavioral/immunological studies that had shown
attenuation of cue-induced drug seeking and opioid-induced conditioned immunomodulation at
these doses/volumes of antagonists (Giertler et al., 2005, Saurer et al., 2006a, Saurer et al.,
2006b, Szczytkowski and Lysle, 2010) and the results of experiment 1. Injector cannulae
extended 2 mm beyond the tip of the guide cannulae and were left in place for 1 min after the
injection to allow for proper drug diffusion.

Following the microinfusions, two groups of animals were re-exposed to the conditioning
chambers (conditioned stimulus, CS) for 60-min in the absence of heroin. The remaining two
groups of animals (home cage, HC) were returned to their home cages to serve as controls. After
the 60-min session in the conditioning chamber or home cage, all animals received a systemic
LPS injection (1000 μg/kg, sc) to induce iNOS, TNF-α and IL-6 production and were then
returned into their home cages. LPS treatment was used in all groups to produce an immune
challenge, as detection of these cytokines and nitric oxide is limited in the absence of an
antigenic challenge. Six hours after LPS administration, all animals were sacrificed and samples
of spleen tissue and blood were collected for analysis. Spleen tissue was collected because LPS
reliably elicits the production nitric oxide in a number of immune cells, including eosinophils,
within the spleen (Bandaletova et al., 1993). The 6-h time point was selected based on previous
research in our laboratory showing maximal iNOS induction 6 h following LPS administration
(Lysle and How, 2000). Previous studies in our laboratory have included control groups that

were exposed to the CS paired with saline during training and animals that received heroin
unpaired with the CS (Lysle and Ijames, 2002, Szczytkowski and Lysle, 2007). Since these
controls were not significantly different from animals that were not re-exposed to the CS on test
day (HC) they were not included in the current study.
2.5. Brain histology

To assess cannula placement, Alcian blue dye was microinfused into the NAC shell and/or BLA
following sacrifice. Brains were then extracted and post-fixed in a 4% paraformaldehyde
solution. Following fixation, the brains were transferred to a 30% sucrose solution for
cryoprotection and then frozen at − 80oC until further analysis. The brains were sectioned in the
coronal plane (50 μm) and were stained using cresyl violet. Cannula placement was examined on
cresyl-violet stained sections and was recorded on appropriate plates of the rat brain atlas of
Paxinos and Watson (1997).
2.6. Measurement of the proinflammatory immune response

To determine iNOS, IL-6, and TNF-α expression, real time RT-PCR was performed on tissue
samples from the spleen. The spleen was selected for analysis because immunohistochemical
localization of iNOS in rats exposed to LPS shows the presence of the iNOS enzyme in a number
of immune cells, including macrophages, lymphocytes, and neutrophils (Bandaletova et al.,
1993). In addition, splenic macrophages also produce IL-6 and TNF-α when activated by LPS.
Total RNA was extracted from a section of each of the tissues using TRI-Reagent (Molecular
Research Center, Cincinnati, OH), a modification of the original method described by
Chomczynski and Sacchi (1987). RNA was quantified spectrophotometrically (GeneQuant II,

Pharmacia-Biotech, Piscataway, NJ, USA). For RT-PCR, reverse transcription was performed
using Oligo(dT)18 primer and Moloney Murine Leukemia Virus-Reverse transcriptase following
the protocol of the Advantage RT-for-PCR Kit from Clontech (Palo Alto, CA, USA).

Specific products from the PCR reaction were detected with Universal ProbeLibrary Probes
(Roche, Indianapolis, IN). In this method, PCR amplifications are performed using standard
protocols, the LightCycler TaqMan Master Real-Time PCR Kit, and the LightCycler instrument
(Roche, Indianapolis, IN). A master mix containing all reaction components was prepared for all
reactions, with each reaction using a 20 ml mix placed in glass capillary tubes specifically
designed for use in the LightCycler system. Primers and probes for genes of interest were as
follows: IL-6, 5′-cctggagtttgtgaagaacaact-3′ and 5′-ggaagttggggtaggaagga-3′ using probe #106;
iNOS, 5′tgaggattacttcttccagctca-3′ and 5′-tgggtgtcagagtcttgtgc-3′ using probe #25; and TNF-α,
5′-gggcctccagaactccag-3′ and 5′-gagcccatttgggaacttct-3′ using probe #98. Primers were
synthesized by the Nucleic Acids Core Facility (Lineberger Cancer Center, UNC-Chapel Hill).
Copy numbers were generated from by an internal standard curve. Amplifications were carried
out for 45 cycles and curves showing fluorescence at each cycle were determined by the
computer software (Roche). Samples were pre-incubated for 10 min at 95o C to activate the FastStart Taq DNA polymerase. The cycle temperatures were 95 and 60 °C for the denaturing and
annealing/extending, respectively. The cycle times were 10 and 30 s for the denaturing and
annealing/extending, respectively. Fluorescence level was determined at the end of the extending
phase for each cycle of PCR. A final cooling phase was carried out at 40 °C for 30 s. The
analysis of the fluorescence level in standards and samples over the course of 45 cycles was used
to derive the number of copies of the target molecule in each sample. Additionally, assessments

of housekeeping gene expression, L13A, were made to assure comparable quality of RNA
among samples. L13A primers were 5′-ccctccaccctatgacaaga-3′ and 5′-ggtacttccacccgacctc-3′
with probe #74. The data are expressed as a ratio of copy number of iNOS (per 10 ng cDNA) to
the housekeeping gene, L13A (per 10 ng cDNA), based on the standard curve using the
Lightcycler software (Roche).

To assess IL-6 and TNF-α protein levels, protein was extracted from a section of each
homogenized tissue using freeze/thaw lysis in tris-buffer containing antiproteinases. Protein was
quantified spectrophotometrically (Bio-Tek, Model EL312 kinetic reader, Winooski, VT, USA)
using Bio-Rad protein dye. To account for variability in tissue size, samples were normalized per
unit protein based on the results of the spectrophotometric analysis. The Invitrogen (Carlsbad,
CA) rat TNF-α and IL-6 ELISA test kits were used to determine the levels of TNF-α and IL-6
protein in each tissue sample. Briefly, samples and standards were added to microtiter wells
coated with antibody that recognizes IL-6 or TNF-α and incubated at room temperature. Wells
were washed extensively and then incubated with biotinylated antibody, followed by a second
wash and then incubation with Streptavidin-HRP. After the final wash, a chromagen substrate
solution was added which reacted with the bound enzyme to produce color. The color intensity
developed proportionally to the amount of IL-6 or TNF-α present in each sample. The enzyme
reaction was stopped after 30 min, and the absorbance at 450 nm was measured with a Bio-Tek
(Winooski, VT) Model EL312 kinetic reader. A standard curve was obtained by plotting the
absorbance versus the corresponding concentrations of the supplied standards.

The level of nitrite/nitrate in plasma samples was assessed using the Greiss reagent assay. Nitrate
and nitrite are formed non-enzymatically when nitric oxide is exposed to oxygen, thus plasma
levels of these products indicate the level of nitric oxide production. Total nitrite/nitrate level is
determined by the conversion of nitrate to nitrite utilizing nitrate reductase in the presence of
NADPH and flavin adenine dinucleotide, and then an assessment using Greiss reagent. Briefly, 6
μl of plasma diluted in 44 μl of dH2O is incubated in the dark for 90-min with 10 μl of nitrate
reductase (1.0 unit/ml), 20 μl of a 0.31 M phosphate buffer (ph 7.5), 10 μl of 0.86 mM NADPH
(Sigma), and 10 μl of a 0.11 mM flavin adenine dinucleotide in individual wells of a 96-well
plate. Then, 200 ml of Griess reagent consisting of a 1:1 (v/v) solution 1% sulfanilamide in 5.0%
phosphoric acid and 0.1% N-(1-napthyl) ethyl-enedamine dihydrochloride in distilled water was
added to the samples. The color developed for 10 min at room temperature after which the
absorbance was determined using a spectrophotometer set at 550 nm. All reactions were carried
out in triplicate. The total micromolar concentration of nitrite is determined for each sample
based on a standard curve. Recovery of nitrate is greater than 95% using this assay.
2.7. Statistical analysis

Analysis of variance (ANOVA) was performed on all data sets with antagonist treatment (saline,
AP-5, CNQX, ipsilateral SCH23390 + AP-5, contralateral SCH23390 + AP-5) and context
(Home Cage, CS Exposed) as between-subjects factors, as appropriate. Statistically significant
interaction effects were followed up by simple main effects tests (t tests) and planned
comparisons evaluating direction-specific hypotheses (one-tail t tests). All analyses were
conducted with the level of significance set at p < 0.05.
3. Results

3.1. Histology

Fig. 1 presents a schematic representation of the cannula placement for both experiments. The
symbols on the schematics (Paxinos and Watson, 1997) represent the most ventral point of the
infusion cannula tracts for rats that received bilateral microinfusions into the NAC shell for
experiment 1 or unilateral microinfusions into the BLA plus the contralateral or ipsilateral NAC
for experiment 2. Cannula placements were located in the ventral aspect of the BLA and the
ventromedial aspect of the NAC, as intended, in order to minimize diffusion into unintended
brain regions. The data of animals with cannula placement outside of the BLA or NAC were not
included in the statistical analyses. The resulting sample sizes per group were as follows:
bilateral NAC shell Saline/home cage (n = 4), bilateral NAC shell Saline/heroin-paired context
(n = 5), bilateral NAC shell AP-5/home cage (n = 5), bilateral NAC shell AP-5/heroin-paired
context (n = 5), bilateral NAC shell CNQX/home cage (n = 4), bilateral NAC shell
CNQX/heroin-paired context (n = 5), ipsilateral Saline/home cage (n = 5), ipsilateral
Saline/heroin-paired context (n = 5), contralateral SCH23390 + AP-5/home cage (n = 5),
contralateral SCH23390 + AP-5/heroin-paired context (n = 5), ipsilateral SCH23390 + AP5/home cage (n = 5), and ipsilateral SCH23390 + AP-5/heroin-paired context (n = 5).

Fig. 1. Schematic representation of injection cannula placements. The symbols on the schematics
(Paxinos and Watson, 1997) represent the most ventral point of the infusion cannula tracts for
rats that received bilateral microinfusions into the NAC for experiment 1 (saline/home cage:
closed squares; saline/heroin-paired context: open squares; AP-5/home cage, closed triangles;

AP-5/heroin-paired context, open triangles; CNQX/home cage, closed circles; CNQX/heroinpaired context, open circles). For experiment 2, symbols represent the most ventral point of the
infusion tract for rats receiving unilateral microinfusions into the BLA plus the contralateral
NAC (home cage, closed circles; heroin-paired context, open circles) or the ipsilateral NAC
(home cage, closed triangles; heroin-paired context, open triangles), or a control microinfusion
of saline into the BLA and NAC (home cage, closed squares; heroin-paired context: open
squares). Numbers indicate the distance from bregma in millimeters.
3.2. Heroin-conditioned suppression of nitric oxide induction requires the stimulation of
ionotropic glutamate receptors in the nucleus accumbens shell

The first study investigated the effect of bilateral intra-NAC shell microinfusions of the NMDA
glutamate receptor antagonist, AP-5, or the AMPA/kainate glutamate receptor antagonist,
CNQX, on the expression of heroin-conditioned suppression of proinflammatory mediators. Six
days following the final conditioning session, animals were re-exposed to the previously heroinpaired environment (CS Exposed) or remained in their home cages (Home Cage) for 60 min. AP5, CNQX, or saline was administered 30 min prior to the test session, whereas LPS was
administered 1 h after the test session.

Fig. 2 shows the effects of AP-5 and CNQX on the LPS-induced expression of splenic iNOS
mRNA levels (upper panel) and serum nitrite/nitrate levels (lower panel) in the groups exposed
to the previously heroin-paired environment or the home cage prior to LPS challenge. Because
nitric oxide is a gaseous molecule with a short half-life, its production was measured indirectly
by analyzing iNOS enzyme mRNA levels in the spleen and the degradation products nitrite and

nitrate in the serum. The ANOVA for LPS-induced iNOS copy number in the spleen revealed a
significant antagonist by context interaction effect [F(2,21) = 4.537, P < 0.05], but no main
effects of antagonist treatment or context. In addition, a separate ANOVA for serum
nitrite/nitrate levels revealed a significant antagonist by context interaction effect [F(2,21) =
10.123, P < 0.01] as well as significant main effects of antagonist treatment [F(2,21) = 4.629, P <
0.05] and context [F(1,21) = 8.593; P < 0.01]. The saline-treated group exposed to the previously
heroin-paired environment exhibited lower splenic iNOS mRNA levels and serum nitrite/nitrate
concentration than the saline-treated home cage control group (t(6) = 2.878; P < 0.05; t(6) =
5.788; P < 0.01, respectively). These changes were similar in intensity to the unconditioned
suppression observed following the administration of heroin itself (Lysle and How, 2000). Most
importantly, unlike in the saline-treated groups, there were no significant differences between the
AP-5-treated or the CNQX-treated group exposed to the previously heroin-paired environment
and their respective home cage control group in splenic iNOS mRNA levels and serum
nitrite/nitrate concentration. These results demonstrate that NMDA or AMPA/kainate receptor
antagonism in the NAC shell blocks the heroin-conditioned suppression in iNOS mRNA
expression and nitrite/nitrate concentration, suggesting a role for these receptors in heroininduced conditioned immunomodulation.

Fig. 2. Effect of antagonist treatment and context on LPS-induced expression of iNOS mRNA in
the spleen as determined by real-time RT-PCR (top panel) and nitrite/nitrate production in the
serum as determined by the Greiss reagent assay (bottom panel). Exposure to the previously
heroin-paired context (Saline, white bar) resulted in conditioned suppression of iNOS mRNA

levels in the spleen and a conditioned suppression of the byproducts of nitric oxide production in
the serum as compared to the home cage control group (Saline, black bar). Intra-NAC
microinfusion of NMDA or AMPA/kainate receptor antagonist blocked the effect of the
conditioned stimulus (AP5/CNQX, white bar). Real-time RT-PCR data are expressed as iNOS
copy number per 10 ng cDNA based on a standard curve using Roche LightCycler software.
Nitrite/nitrate data are expressed as the micromolar concentration of nitrite/nitrate.
3.3. Heroin-conditioned suppression of TNF-α production requires the stimulation of ionotropic
glutamate receptors in the nucleus accumbens shell

Exposure to a previously heroin-paired environment induces a conditioned suppression of the
proinflammatory cytokine, TNF-α (Szczytkowski and Lysle, 2008). Fig. 3 illustrates that this
conditioned suppressive effect of heroin on TNF-α expression is blocked by antagonism of
glutamate AMPA/kainate or NMDA receptors within the NAC shell. The ANOVA for splenic
TNF-α mRNA levels revealed an antagonist treatment by context interaction effect [F(2,21) =
3.831, p < 0.05] but no antagonist treatment or context main effects. Similarly, the ANOVA for
splenic TNF-α protein levels revealed an antagonist treatment by context interaction effects
[F(2,21) = 3.737, p < 0.05] and an antagonist treatment main effect [F(2,21) = 3.901, p < 0.05]
but no context main effect. In line with our previous experiments, the saline-treated group
exposed to the previously heroin-paired environment exhibited significantly lower levels of
TNF-α mRNA and protein in the spleen as compared to the saline-treated home cage control
group (one-tail t(6) = 1.995; P < 0.05; t(6) = 2.514; P < 0.05, respectively). Most importantly,
unlike in the saline-treated groups, there were no significant differences between the AP-5treated or the CNQX-treated group exposed to the previously heroin-paired environment and the

respective home cage control group in TNF-α mRNA and protein levels in the spleen. These data
indicate that NMDA or AMPA/kainate receptor antagonism in the NAC shell attenuated the
heroin-conditioned suppression in LPS-induced TNF-α expression.

Fig. 3. Effect of antagonist treatment and context on LPS-induced expression of TNF-α mRNA
in the spleen as determined by real-time RT-PCR (top panel) and TNF-α protein levels as
determined by ELISA (bottom panel). Exposure to the previously heroin-paired context (Saline,
white bar) resulted in a conditioned suppression of TNF-α mRNA and protein levels in the
spleen as compared to the home cage control group (Saline, black bar). Intra-NAC microinfusion
of NMDA or AMPA/kainate receptor antagonist blocked the effect of the conditioned stimulus
(AP5/CNQX, white bar). Real-time RT-PCR data are expressed as TNF-α copy number per 10
ng cDNA based on a standard curve using Roche LightCycler software. ELISA data are
expressed as pg of TNF-α protein per mg of total protein.
3.4. Heroin-conditioned suppression of IL-6 production requires the stimulation of ionotropic
glutamate receptors in the nucleus accumbens shell

Fig. 4 shows that the suppressive effect of heroin on the production of the proinflammatory
cytokine, IL-6, can be conditioned to environmental stimuli and, again, this conditioned effect is
reduced by antagonism of either AMPA/kainate or NMDA receptors within the NAC shell. This
effect was evident at the mRNA, but not the protein level, in the spleen. The ANOVA for splenic
IL-6 mRNA levels revealed a significant antagonist treatment by context interaction effect in
[F(2,21) = 4.021, p < 0.05] but no antagonist treatment or context main effects. Although the

direction of the effect was as expected, the ANOVA for splenic IL-6 protein levels did not
indicate a significant antagonist treatment by context interaction effect [F(2,21) = 2.341, p =
.121] or main effects. In line with our previous experiments, the saline-treated group exposed to
the previously heroin-paired environment on the test day exhibited significantly lower levels of
IL-6 mRNA in the spleen compared to the saline-treated home cage control group (t(6) = 3.923;
P < 0.01). Again, although the expected effect for IL-6 protein was evident the t-test did not
achieve statistical significance. Conversely, there were no significant differences between the
AP-5-treated or the CNQX-treated group exposed to the previously heroin-paired environment
and its respective home cage control group in IL-6 mRNA levels in the spleen, showing that
antagonism of either AMPA/kainate or NMDA receptors within the NAC shell blocked the
heroin-conditioned suppression of LPS-induced IL-6 mRNA expression.

Fig. 4. Effect of antagonist treatment and context on LPS-induced expression of IL-6 mRNA in
the spleen as determined by real-time RT-PCR (top panel) and IL-6 protein in the spleen as
determined by ELISA (bottom panel). Exposure to the previously heroin-paired context (Saline,
white bar) resulted in a conditioned suppression of IL-6 mRNA levels in the spleen as compared
to the home cage control group (Saline, black bar). Intra-NAC microinfusion of NMDA or
AMPA/kainate receptor antagonist blocked the effect of the conditioned stimulus (AP5/CNQX,
white bar). Real-time RT-PCR data are expressed as iNOS copy number per 10 ng cDNA based
on a standard curve using Roche LightCycler software. ELISA data are expressed as pg of IL-6
protein per mg of total protein.

3.5. Heroin-conditioned suppression of nitric oxide production depends on the integrity of the
VTA–BLA–NAC circuit

Experiment 2 investigated the expression of heroin-induced conditioned suppression of proinflammatory mediators following functional disconnection of a circuitry comprised of the VTA,
D1-receptor-bearing neurons in the BLA, and NMDA receptor-bearing neurons in the NAC
shell. On the test day, animals were re-exposed to the previously heroin-paired environment for
60 min or remained in the home cage. To disconnect the above circuitry prior to testing of the
conditioned response, animals received a unilateral microinfusion of the D1 antagonist,
SCH23390, into the BLA coupled with a unilateral microinfusion of the NMDA antagonist, AP5, into the contralateral NAC shell. One control group received ipsilateral infusions of
SCH23390 into the BLA and AP-5 into the NAC. Additional control groups received saline
microinfusions into the contralateral or ipsilateral BLA and the NAC shell.

Fig. 5 shows the mean levels of LPS-induced iNOS mRNA expression in the spleen (upper
panel) and the LPS-induced nitrite/nitrate concentrations in the serum (lower panel) for each
group. The ANOVA for splenic iNOS mRNA levels revealed a significant antagonist treatment
by context interaction effect [F(2,24) = 5.252, P < 0.05], as well as significant context [F(1,24) =
18.647, P < 0.01] and antagonist treatment main effects [F(2,24) = 10.675, P < 0.01]. Similarly,
the ANOVA for serum nitrite/nitrate concentration revealed a significant antagonist treatment by
context interaction effect [F(2,24) = 6.677, P < 0.05], as well as significant context [F(1,24) =
8.737, P < 0.01] and antagonist treatment main effects [F(2,24) = 8.474, P < 0.01]. The salinetreated group exposed to the previously heroin-paired environment on the test day exhibited

significantly lower splenic iNOS copy number and serum nitrite/nitrate concentration compared
to the saline-treated home cage control group (t(8) = 6.884; P < 0.01; t(8) = 5.371; P < 0.01,
respectively). These data reconfirm our earlier findings indicating that exposure to a previously
heroin-paired environment suppresses splenic iNOS mRNA expression and serum nitrite/nitrate
levels. Similarly, the group that received ipsilateral SCH23390 plus AP-5 treatment prior to
exposure to the previously heroin-paired environment exhibited significantly lower iNOS copy
number and nitrite/nitrate concentration compared to the ipsilaterally-treated home cage control
group (t(8) = 5.131; P < 0.01; t(8) = 4.519; P < 0.01, respectively). Most importantly, however,
there was no difference between the group that received contralateral SCH23390 plus AP-5
treatment prior to exposure to the previously heroin-paired environment and the contralaterallytreated home cage control group in iNOS copy number or nitrite/nitrate concentration. These
findings indicate that functional disconnection of the VTA–BLA–NAC circuitry blocks the
heroin-conditioned suppression of LPS-induced nitric oxide production.

Fig. 5. Effect of antagonist treatment and context on LPS-induced expression of iNOS mRNA in
the spleen as determined by real-time RT-PCR (top panel) and nitrite/nitrate production in the
serum as determined by the Greiss reagent assay (bottom panel). Exposure to the previously
heroin-paired context (Saline, white bar) resulted in a conditioned suppression of iNOS mRNA
levels in the spleen and a conditioned suppression of the byproducts of nitric oxide production in
the serum as compared to the home cage control group (Saline, black bar). Disconnection of the
VTA–BLA–NAC circuit blocked the effect of the conditioned stimulus (Contralateral, white
bar). Ipsilateral administration of intra-NAC AP5 and intra-BLA SCH23390 did not alter the

conditioned suppression (Ipsilateral, white bar). Real-time RT-PCR data are expressed as iNOS
copy number per 10 ng cDNA based on a standard curve using Roche LightCycler software.
Nitrite/nitrate data are expressed as the micromolar concentration of nitrite/nitrate.
3.6. Heroin-conditioned suppression of TNF-α expression depends on the integrity of the VTA–
BLA–NAC circuitry

Fig. 6 shows the mean levels of LPS-induced TNF-α expression for each group. The ANOVA
for splenic TNF-α mRNA levels revealed significant context [F(1,24) = 6.171, P < 0.05] and
antagonist treatment main effects [F(1,24) = 3.498, P < 0.05] but no antagonist treatment by
context interaction effect. Furthermore, the ANOVA for TNF-α protein levels revealed a
significant context main effect [F(1,24) = 5.06, P < 0.05] but not antagonist treatment main effect
or antagonist treatment by context interaction effect. However, planned comparisons indicated
that the groups that received saline or ipsilateral SCH23390 plus AP-5 treatment prior to
exposure to the previously heroin-paired environment exhibited lower TNF-α mRNA (t(8) =
3.711; P < 0.01; t(8) = 2.832; P < 0.05, respectively) and protein levels (t(8) = 2.426; P < 0.05;
t(8) = 2.312; P < 0.05, respectively) compared to the respective home cage control groups.
Conversely, there were no differences between the groups that received contralateral SCH23390
and AP-5 prior to exposure to the previously heroin-paired environment and the respective home
cage control group in TNF-α mRNA or protein levels. These findings indicate that functional
disconnection of the VTA–BLA–NAC circuitry blocks the heroin-conditioned suppression of
LPS-induced TNF-α expression.

Fig. 6. Effect of antagonist treatment and context on LPS-induced expression of TNF-α mRNA
in the spleen as determined by real-time RT-PCR (top panel) and TNF-α protein levels as
determined by ELISA (bottom panel). Exposure to the previously heroin-paired context (Saline,
white bar) resulted in a conditioned suppression of TNF-α mRNA and protein levels in the
spleen as compared to the home cage control group (Saline, black bar). Disconnection of the
VTA–BLA–NAC circuit blocked the effect of the conditioned stimulus (Contralateral, white
bar). Ipsilateral administration of intra-NAC AP5 and intra-BLA SCH23390 did not alter the
conditioned suppression of TNF-α (Ipsilateral, white bar). Real-time RT-PCR data are expressed
as TNF-α copy number per 10 ng cDNA based on a standard curve using Roche LightCycler
software. ELISA data are expressed as pg of TNF-α protein per mg of total protein.
3.7. Heroin-conditioned suppression of IL-6 expression depends on the integrity of the VTA–
BLA–NAC circuitry

Fig. 7 shows the suppressive effect of heroin on IL-6 mRNA and protein expression in the spleen
for each group. The ANOVAs for splenic IL-6 mRNA and protein levels revealed significant
context main effects [F(1,24), P < 0.01; F(1,24) = 11.514, P < 0.01, respectively] but no
antagonist treatment main or antagonist treatment by context interaction effect. However,
planned comparison revealed that the groups that received saline or ipsilateral SCH23390 plus
AP-5 treatment prior to exposure to the previously heroin-paired environment exhibited lower
IL-6 mRNA expression (t(8) = 4.12, P < 0.01; one-tail t(8) = 2.273; P < 0.05, respectively) and
IL-6 protein levels (t(8) = 4.569; P < 0.01; one-tail t(8) = 2.02; P < 0.05, respectively) compared
to the respective home cage control groups. Conversely, there were no differences between the
groups that received contralateral SCH23390 and AP-5 prior to exposure to the previously

heroin-paired environment and the respective home cage control group in splenic IL-6 mRNA
and protein levels. These findings indicate that functional disconnection of the VTA–BLA–NAC
circuitry blocks the heroin-conditioned suppression of LPS-induced IL-6 expression.

Fig. 7. Effect of antagonist treatment and context on LPS-induced expression of IL-6 mRNA in
the spleen as determined by real-time RT-PCR (top panel) and IL-6 protein in the spleen as
determined by ELISA (bottom panel). Exposure to the previously heroin-paired context (Saline,
white bar) resulted in a conditioned suppression of IL-6 mRNA and protein levels in the spleen
as compared to the home cage control group (Saline, black bar). Disconnection of the VTA–
BLA–NAC circuit blocked the effect of the conditioned stimulus (Contralateral, white bar).
Ipsilateral administration of intra-NAC AP5 and intra-BLA SCH23390 did not alter the
conditioned suppression of IL-6 (Ipsilateral, white bar). Real-time RT-PCR data are expressed as
IL-6 copy number per 10 ng cDNA based on a standard curve using Roche LightCycler software.
ELISA data are expressed as pg of IL-6 protein per mg of total protein.
4. Discussion

Although our laboratory and others have previously identified key brain areas involved in
conditioned immunomodulation, the experiments reported here are the first to identify a specific
neural circuit critical for the expression of the effects of heroin-related cues on immune
functioning. Specifically, they indicate that stimulation of ionotropic glutamate receptors in the
NAC shell as well as communication between the VTA, D1 dopamine receptor-bearing neurons
in the BLA, and NMDA receptor-bearing neurons in the NAC shell are necessary for the ability

of a heroin-paired context to suppress the production of proinflammatory modulators in response
to LPS immune challenge. The production of proinflammatory modulators is a critical
component of host immune response to pathogenic challenge and any disruption of this process
in current or recovering heroin users may manifest as a decreased ability to combat infectious
diseases even after achieving drug abstinence. This, in turn, increases the risk of opportunistic
infections and can result in other problems related to decreased immunity, such as deficient
antibody responses to vaccination.

The results of experiment 1 demonstrate that glutamatergic signaling within the NAC shell plays
a critical role in the conditioned effects of heroin on proinflammatory mediators. In particular,
antagonism of either NMDA or AMPA/kainate receptors within the NAC shell blocked the
expression of heroin-conditioned suppression of LPS-induced nitric oxide, TNF-α, and IL-6
expression providing exciting new information regarding the role of the NAC in heroin-induced
conditioned immunomodulation. Similarly, NMDA or AMPA/kainate receptor antagonism in the
NAC prevents drug context-induced drug-seeking behavior (Xie et al., in press) and 7-OHDPAT-conditioned place preference (Biondo et al., 2005), conditioned behaviors based on
associations between environmental stimuli and the primary rewarding effects of 7-OH-DPAT.
Together, these and the present findings indicate a general role for NAC NMDA and AMPA
receptors in Pavlovian conditioned responses, including conditioned immunomodulatory
responses.

Recent research from our laboratory revealed that antagonism of dopamine D1, but not D2,
receptors within the BLA blocks the conditioned effects of heroin on proinflammatory mediators

(Szczytkowski and Lysle, 2010). Importantly, the BLA directly innervates the NAC via
glutamatergic afferents (Wright and Groenewegen, 1995, Wright et al., 1996, Sesack and Grace,
2010). Furthermore, functional disconnection studies have demonstrated that the establishment
of conditioned reinforcers and second-order Pavlovian conditioning are dependent on
interactions between the BLA and the NAC (Baldwin et al., 2000, Setlow et al., 2002, Di Ciano
and Everitt, 2004), supporting the hypothesis that communication within the VTA–BLA–NAC
circuitry may be necessary for the expression of conditioned immunomodulation. To investigate
this hypothesis, we used a functional disconnection procedure (Setlow et al., 2002, Di Ciano and
Everitt, 2004, Fuchs et al., 2007, Lasseter et al., 2011). In addition, we took advantage of the fact
that, in the rat, the primary source of dopamine to the BLA is the VTA (Ford et al., 2006), in
order to obtain a triple disconnection manipulation. Accordingly, in experiment 2, unilateral
intra-BLA administration of the D1 receptor antagonist, SCH23390, was coupled with
contralateral intra-NAC shell administration of the NMDA antagonist, AP-5, in order to
functionally disconnect the VTA–BLA–NAC neural circuit prior to the testing of the conditioned
immune response. Remarkably, functional disconnection of the VTA–BLA–NAC neural circuit
blocked the expression of heroin-conditioned suppression of the LPS-induced proinflammatory
response. Conversely, ipsilateral manipulation of the same neural circuit, which antagonizes the
same amount of neural tissue but leaves communication within the VTA–BLA–NAC neural
circuit intact in one hemisphere, failed to impair the heroin-conditioned suppression of this
proinflammatory response. These data indicate that sequential information processing by the
VTA, D1 dopamine-bearing neurons in the BLA, and NMDA receptor-bearing neurons in the
NAC shell is necessary for heroin-induced conditioned immunomodulation and define, for the
first time, a specific neural circuit involved in neural-immune interactions.

It important to note that additional interactions between the VTA, BLA, and NAC and
communication with other brain regions are likely to critically contribute to heroin-induced
conditioned immunomodulation. Thus, further characterization of the larger neural circuit
responsible for this conditioned immune effect will be imperative. First, the present study
identifies the BLA as a necessary source of glutamatergic input to the NAC for the expression of
conditioned immunomodulation; however, the NAC receives glutamatergic input from numerous
other brain regions, including the dorsal hippocampus and prelimbic cortex, which may be
elements of the circuitry. In fact, preliminary studies in our laboratory suggest that the dorsal
hippocampus also plays a role in heroin-conditioned suppression of LPS-induced immune
responses (Szczytkowski et al., unpublished observations). Future disconnection studies will
need to establish, however, whether the dorsal hippocampus contributes to these responses as
part of the currently known or a separate neural circuit. Second, our laboratory has shown that
intra-NAC shell administration of the dopamine D1 receptor antagonist, SCH23390, blocks the
unconditioned effects of morphine and the conditioned effects of morphine-paired environmental
stimuli on natural killer cell activity and nitric oxide production (Saurer et al., 2006a, Saurer et
al., 2006b, Saurer et al., 2009). Taken together with the present findings, these data indicate that
both glutamatergic and dopaminergic receptor stimulation within the NAC is necessary for the
expression of opioid-induced conditioned immunomodulation. Furthermore, pyramidal cell
projections from the BLA synapse in close proximity to dopamine axons on medium spiny
neurons of the NAC (Kelley et al., 1982, Robinson and Beart, 1988, Johnson et al., 1994),
suggesting that conditioned immune regulation may be a result of complex interaction between
dopamine and glutamate within the NAC. Third, the hypothalamus likely acts as an interface

between the central nervous system and autonomic centers that control peripheral immune
response, including those observed in the present study in the spleen and blood plasma.
Consistent with this, various hypothalamic nuclei exhibit robust Fos protein expression, a marker
of neural activation, in association with morphine-induced immunomodulation (Saurer & Lysle,
unpublished observation). Thus, future studies will ascertain whether neural activity within these
regions of the hypothalamus is also integral to opioid-conditioned immunomodulatory responses.

While the exact peripheral mechanisms modulating the alterations in proinflammatory mediators
observed in response to exposure to opioid-associated drug cues are unknown, research has
revealed potential mechanisms. Given the connectivity of the hypothalamus with the autonomic
nervous system and its control over the release of various peripheral neuroendocrine mediators,
this brain region may serve as the relay between the CNS and the immune system. For example,
cocaine-associated cues induce concomitant alterations in immune functioning, including TNF-α
production, and in corticosterone levels, suggesting the HPA axis may be involved in drug cuemediated conditioned immunomodulation (Kubera et al., 2008). Alternatively, the sympathetic
nervous system innervates both primary and secondary lymphoid tissues and releases molecules
that interact with receptors on immune cells (Williams et al., 1981, Felten et al., 1984). In fact,
sympathetic innervation of the spleen provides some of the most concrete evidence for
communication between the nervous and immune systems through the release of norepinephrine
(and other chemicals) from sympathetic nerve fibers onto immune cells in this organ. In support
of this possibility, previous research from our laboratory has shown that the suppression of
splenic mitogenic responsiveness observed following exposure to an aversive CS can be blocked
by administration of the beta-adrenergic receptor antagonist, propanolol (Lysle et al., 1991).

Similarly, the expression of a subset of morphine-induced conditioned immune alterations is
blocked by systemic administration of the non-selective peripheral β-adrenergic receptor
antagonist, nadolol (Coussons-Read et al., 1994). The sympathetic nervous system may also be
involved in the unconditioned effects of morphine on immunity as beta-adrenergic receptor
antagonism attenuate the morphine-induced suppression of lymphocyte proliferation (Fecho et
al., 1993). Furthermore, the conditioned and unconditioned effects of opiates on NK cell
cytotoxicity appears to be mediated by neuropeptide Y, a peptide transmitter co-released with
norepinephrine by the sympathetic nervous system (Saurer et al., 2006a, Saurer et al., 2006b,
Saurer et al., 2008). Collectively these data suggest a possible role for the hypothalamus and the
sympathetic nervous system in the modulation of opiate-induced conditioned
immunomodulation.

Exposure to drug-associated environmental stimuli may have widespread implications for the
health outcomes of both current and former opiate users. For this reason, it is crucial that the
mechanisms by which previously heroin-paired stimuli alter the immune response are elucidated.
A clear understanding of the neurotransmitters and neural circuitry involved in heroinconditioned immunomodulation will be needed for the targeted development of pharmaceuticals
that restore immune function in susceptible populations, allowing pharmacotherapeutic
intervention before infections lead to irreversible organ damage and other detrimental health
consequences. These effects need to be factored into the comprehensive treatment—including
substitution therapy and pain management—of both current and former opiate users.
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